EuroPCR 2026, the world’s leading course in interventional cardiovascular medicine, was held from May 19–22 in Paris, France, bringing together physicians, healthcare professionals, and industry representatives from around the world.

During the congress, APT Medical engaged with the international interventional community through a comprehensive program of educational workshops, clinical discussions, and practical learning across APT Training Village T05 and Booth M52.

A key highlight of APT Medical’s participation was a series of interactive CTO workshops led by nine international CTO experts from Europe, Asia, and the Middle East. The sessions focused on practical strategies in complex PCI, including CTO crossing techniques, device selection, procedural planning, and real-world procedural perspectives. Through case-based presentations, procedural discussion, and interactive hands-on learning, participants were able to engage directly with experienced operators and explore practical solutions for challenging interventions.

More than 200 physicians participated in APT Medical’s Training Village activities throughout the congress, reflecting strong interest in practical CTO education and complex PCI learning.

In addition to the workshops, APT Medical presented its latest solutions for complex coronary intervention at Booth M52, supporting meaningful exchange with physicians and partners from around the world. The booth served as an important platform for clinical dialogue, professional interaction, and international collaboration during the congress.

“EuroPCR remains an important platform for advancing education, innovation, and clinical exchange in interventional cardiology,” said the APT Medical international team. “We are honored to collaborate with physicians and partners worldwide through practical learning and meaningful clinical exchange.”

APT Medical extends its sincere appreciation to all faculty members, physicians, partners, and visitors who contributed to the success of this year’s activities. The company remains committed to supporting physician education, global collaboration, and innovation in complex PCI and interventional cardiology worldwide.